PanTum® Detect is a multi-tumor screening blood test that “filters” asymptomatic healthy individuals by screening for the presence of silently growing benign, premalignant or malignant tumors.
The test has an IVD CE certified sensitivity of 97.5% and a specificity of 99%. It uses EDIM® (Epitope Detection in Monocytes) technology to detect multi-tumor enzyme biomarkers Apo10 & TKTL1 in immune cells (macrophages) which are detectable in all phases of tumor development.
This revolutionary, thoroughly researched and scientifically proven technology leverages the human immune system thus making it possible to detect tumors in early stages.
The “Cancer-Scan” program combines blood testing for PanTum® Detect with advanced imaging techniques and pathology confirmation into an integrated multi-tumor screening concept for early tumor detection.
Technology behind PanTum® Detect Test
Leveraging the immune system to deliver high accuracy of PanTum® Detect test
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.
OUR EXPERTSWe'll Ensure You Always Get the Best Results
"Pantum® Detect is a truly innovative and revolutionary test in the field of cancer management. It is the holy grail of a universal test with a high sensitivity and specificity for the detection of early cancer."
Dr. Gurdeep Singh Sethi, MD
CO-FOUNDER & DIRECTOR
Medidect™ India - A Unit of Millennium Oncology India Private Limited